For detailed dosing information, please see the Prescribing Information.
Recommended dosing for treatment of bleeding episodes and surgery.1
Keep NovoSeven® RT on hand to treat as soon as possible after a bleeding episode starts.

CONGENITAL HEMOPHILIA A OR B WITH INHIBITORS
(for perioperative management)
MINOR:
Initial:
90 mcg/kg immediately before surgery
repeat every 2 hours for the duration of the surgery
Post surgical:
90 mcg/kg every 2 hours after surgery for 48 hours
then every 2-6 hours until healing occurs
MAJOR:
Initial:
90 mcg/kg immediately before surgery
repeat every 2 hours for the duration of the surgery
Post surgical:
90 mcg/kg every 2 hours after surgery for 5 days
then every 4 hours or by continuous infusion at 50 mcg/kg/hr until healing occurs
ACQUIRED HEMOPHILIA
(for perioperative management)
MINOR OR MAJOR:
70-90 mcg/kg immediately before surgery and every 2-3 hours
for the duration of surgery and until hemostasis is achieveda
CONGENITAL FACTOR VII
(for perioperative management)
MINOR OR MAJOR:
15-30 mcg/kg immediately before surgery and every 4-6 hours
for the duration of surgery and until hemostasis is achieveda
GLANZMANN’S THROMBASTHENIA
WITH REFRACTORINESS TO PLATELET TRANSFUSIONS, WITH OR WITHOUT ANTIBODIES TO PLATELETS
(for perioperative management)
MINOR OR MAJOR:
Initial:
90 mcg/kg immediately before surgery and every 2 hours
for the duration of the procedurea
Post surgical:
90 mcg/kg every 2 hours to prevent post-operative bleedinga
Higher doses of 100-140 micrograms per kg can be used for surgical patients who have clinical refractoriness with or without platelet-specific antibodies
aThe minimum effective dose has not been determined.

Find the right dose for
your patients.
![Preparing NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) Injection](/content/dam/novonordisk/novosevenpro/dosing/cta-mixpro.jpg)